MedPath

Influence of proton pump inhibitors on nonsteroidal anti-inflammatory drug-induced small-intestinal lesions

Phase 1
Conditions
nonsteroidal antiinflammatory drug induced small intestinal lesions
Registration Number
JPRN-UMIN000024833
Lead Sponsor
Second Department of Internal Medicine, Osaka Medical College
Brief Summary

terminate this trial to change the protocol

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

(1)a history of allergy to diclofenac, rabeprazole, vonoprazan (2)a history of peptic ulcers or gastrointestinal bleeding, ulcerative colitis, Crohn' s disease (3)a history of gastrointestinal surgery other than appendectomy (4)a history of intestinal obstruction or suspected gastrointestinal obstruction on other tests (5)significant hepatic, renal, heart, or respiratory disease (6)Pregnant women, those who may become pregnant during the study period, and lactating women (7)a lack of consent for the surgery required if the capsule endoscope was retained within the body (8)determination by the investigator (at his/her discretion) that the subject was ineligible for participation in the study for any other reason

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of mucosal breaks (erosion, ulcer) in the small intestine on capsule endoscopy at the completion of administration
Secondary Outcome Measures
NameTimeMethod
umber of sites of redness in the small intestine on capsule endoscopy at the completion of administration, Lewis score, fecal Calprotectin, serum DAO activity, and adverse effects
© Copyright 2025. All Rights Reserved by MedPath